BRIEF published on 11/06/2024 at 07:35, 5 months 1 day ago R. STAHL annonce une augmentation de ses ventes et met à jour ses prévisions de bénéfices pour 2024 R. STAHL Investissements Stratégiques Prévisions De Bénéfices Performances De Vente Prise De Commande
PRESS RELEASE published on 11/06/2024 at 07:30, 5 months 1 day ago R. STAHL significantly increases sales in the first nine months of 2024 and specifies earnings forecast R. STAHL significantly increases sales in the first nine months of 2024 and specifies earnings forecast. Sales up 8.6% to €261.4 million, EBITDA margin pre exceptionals at 10.7% Financial Performance EBITDA Margin Earnings Forecast Sales Increase R. STAHL
BRIEF published on 10/23/2024 at 09:07, 5 months 15 days ago R. Stahl AG maintient de solides perspectives malgré des attentes modestes pour le troisième trimestre Croissance Des Ventes R. Stahl AG Prise De Commande Attentes Pour Le Troisième Trimestre Défis De Rentabilité
BRIEF published on 10/23/2024 at 09:07, 5 months 15 days ago R. Stahl AG Maintains Solid Prospects Amidst Modest Q3 Expectations Sales Growth Order Intake R. Stahl AG Q3 Expectations Profitability Challenges
PRESS RELEASE published on 10/23/2024 at 09:02, 5 months 15 days ago Original-Research: R. STAHL AG (von NuWays AG): Buy NuWays AG releases updated research on R. STAHL AG, predicting solid Q3 results and FY guidance achievement, reiterating a Buy rating with a target price of EUR 29.00 NuWays AG BUY Rating Q3 Results Research R. Stahl AG
BRIEF published on 08/09/2024 at 09:07, 7 months 29 days ago NuWays AG confirme sa note d'achat pour R. Stahl AG NuWays AG R. Stahl AG Acheter Une Note Performances Du Deuxième Trimestre Orientation Pour L'exercice Financier
BRIEF published on 08/09/2024 at 09:07, 7 months 29 days ago NuWays AG Confirms BUY Rating for R. Stahl AG NuWays AG BUY Rating R. Stahl AG Q2 Performance FY Guidance
PRESS RELEASE published on 08/09/2024 at 09:02, 7 months 29 days ago Original-Research: R. STAHL AG (von NuWays AG): BUY R. STAHL AG (DE000A1PHBB5) receives a BUY recommendation from NuWays AG after strong Q2 results. FY24e guidance confirmed. Analyst: Christian Sandherr Buy Recommendation FY24 Guidance R. Stahl AG Q2 Results Christian Sandherr
BRIEF published on 08/08/2024 at 07:35, 7 months 30 days ago R. STAHL Reports Robust Growth in H1 2024, Enhanced Profitability in Q2 EBITDA Sales Growth Order Backlog R. STAHL Q2 Profitability
BRIEF published on 08/08/2024 at 07:35, 7 months 30 days ago R. STAHL annonce une croissance robuste au premier semestre 2024 et une rentabilité améliorée au deuxième trimestre BAIIA La Croissance Des Ventes Carnet De Commandes R.STAHL Rentabilité Du Deuxième Trimestre
Published on 04/07/2025 at 08:00, 3 hours 50 minutes ago Pulsar Helium Announces Notice of 2025 Annual General and Special Meeting of Shareholders
Published on 04/07/2025 at 00:05, 11 hours 45 minutes ago Sea Pharmaceuticals Announces Strategic Relationship to Advance Treatments For Patients with CNS Disorders
Published on 04/05/2025 at 01:50, 2 days 10 hours ago Battery X Metals Achieves Graphite Recovery Breakthrough in Partnership with Global Top 20 University in Controlled Trials
Published on 04/07/2025 at 11:18, 31 minutes ago Cerinnov Group: DECLARATION MENSUELLE DU NOMBRE D’ACTIONS ET DE DROITS DE VOTES
Published on 04/07/2025 at 10:30, 1 hour 19 minutes ago Original-Research: UmweltBank AG (von GBC AG): Buy
Published on 04/07/2025 at 09:06, 2 hours 43 minutes ago A taboo subject: Younger people talk more openly about their salary than older people — but shy away from negotiation
Published on 04/07/2025 at 09:00, 2 hours 49 minutes ago Original-Research: Borussia Dortmund GmbH & Co KGaA (von NuWays AG): BUY
Published on 04/07/2025 at 09:00, 2 hours 50 minutes ago Julius Meinl Living Publishes its Consolidated 2024 Accounts
Published on 04/07/2025 at 07:01, 4 hours 49 minutes ago bioMérieux obtient le marquage CE pour LUMED™ APSS™, une solution logicielle de pointe pour aider à prendre des décisions en matière de bon usage des antibiotiques
Published on 04/07/2025 at 07:01, 4 hours 49 minutes ago bioMérieux obtains CE-marking for LUMED™ APSS™, a cutting-edge software solution to aid medical decision-making in Antimicrobial Stewardship
Published on 04/04/2025 at 19:18, 2 days 16 hours ago Mersen: Number of shares and voting rights as of March 31, 2025
Published on 04/04/2025 at 19:18, 2 days 16 hours ago Mersen : nombre d'actions et de droits de vote au 31 mars 2025
Published on 04/04/2025 at 18:17, 2 days 17 hours ago Reporting on share buyback transactions carried out between March 31 and April 3, 2025
